Merck, Schering-Plough under House investigation over Zetia trial Ulta posts quarterly results, sees double-digit sales gains NACDS hails passage by House members of equal-access provisions of military bill Merck's annual briefing includes updates on new business plan FDA grants Mylan tentative approval for generic Lamictal AmerisourceBergen expects possible 20 percent earnings increase FDA panel votes in favor of vernakalant approval Simulations Plus signs multi-year deal with major pharma company NoMoreClipboard.com, ReliefInsite.com partner to offer online pain management module FDA requires added warning about carbamazepine for Asians First Previous 2617 2618 2619 2620 2621 Next Last